{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:58:07Z","timestamp":1788933487092,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":508,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.anpedi.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T03:54:57Z","timestamp":1476676497000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Consumo de medicamentos en el embarazo y riesgo de anomal\u00edas cong\u00e9nitas en la Comunitat Valenciana"],"prefix":"10.1016","volume":"87","author":[{"given":"Clara","family":"Cavero-Carbonell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gimeno-Martos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"P\u00e1ramo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Rabanaque-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Martos-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Zurriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2016.08.003_bib0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semerg.2009.12.012","article-title":"Caracter\u00edsticas generales de los defectos cong\u00e9nitos, terminolog\u00eda y causas","volume":"36","author":"Mart\u00ednez-Fr\u00edas","year":"2010","journal-title":"Semergen."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0205","unstructured":"EUROCAT [Internet]. The status of health in the European Union: Congenital malformations [aprox. 2 pantallas]. June 2009 [consultado 17 Jun 2015]. Disponible en: http:\/\/www.eurocat-network.eu\/memberreg\/."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0210","series-title":"Rare diseases epidemiology. Avances in Experimental Medicine and Biology","first-page":"349","article-title":"The prevalence of congenital anomalies in Europe","author":"Dolk","year":"2010"},{"key":"10.1016\/j.anpedi.2016.08.003_bib0215","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/bdra.20193","article-title":"Gene-environment interactions in rare diseases that include common birth defects","volume":"73","author":"Graham","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.medcli.2011.10.011","article-title":"Talidomida: 50 a\u00f1os despu\u00e9s","volume":"139","author":"Mart\u00ednez-Fr\u00edas","year":"2012","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/humupd\/dmp052","article-title":"Teratogenic mechanisms of medical drugs","volume":"16","author":"Van Gelder","year":"2010","journal-title":"Hum Reprod Update."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0230","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1210\/jc.2010-0652","article-title":"Treatment of hyperthyroidism in pregnancy and birth defects","volume":"95","author":"Clementi","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0235","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/bdra.23012","article-title":"Pharmacologic treatment of hyperthyroidism during pregnancy","volume":"94","author":"Cassina","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0240","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","article-title":"Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study","volume":"163","author":"Crider","year":"2009","journal-title":"Arch Pediatr Adolesc Med."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0245","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/EDE.0b013e318258cb05","article-title":"Maternal exposure to amoxicillin and the risk of oral clefts","volume":"23","author":"Lin","year":"2012","journal-title":"Epidemiology."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0250","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/14737175.6.6.833","article-title":"Birth defects and epilepsy medication","volume":"6","author":"Adab","year":"2006","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0255","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.wnl.0000316194.98475.d8","article-title":"Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?","volume":"71","author":"Dolk","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/jpm.2010.139","article-title":"Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication","volume":"39","author":"Watts","year":"2011","journal-title":"J Perinat Med."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.109.129098","article-title":"Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations","volume":"54","author":"Caton","year":"2009","journal-title":"Hypertension."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0270","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0447.2011.01673.x","article-title":"Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects","volume":"123","author":"Gentile","year":"2011","journal-title":"Acta Psychiatr Scand."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0275","doi-asserted-by":"crossref","first-page":"51.e1","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0280","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/bdra.20599","article-title":"Perspectives of primary care clinicians on teratogenic risk counseling","volume":"85","author":"Schwarz","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0285","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00228-008-0546-y","article-title":"Prescription drug use during pregnancy: A population-based study in Regione Emilia-Romagna, Italy","volume":"64","author":"Gagne","year":"2008","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0290","first-page":"51","article-title":"GAIA: Gestor Integral de Prestaci\u00f3n Farmac\u00e9utica","volume":"1","year":"2002","journal-title":"Bolet\u00edn Farmacoterap\u00e9utico Valenciano"},{"key":"10.1016\/j.anpedi.2016.08.003_bib0295","unstructured":"EUROCAT [Internet]. EUROCAT Guide 1.3 and reference documents. Instructions for the registration and surveillance of congenital anomalies. [aprox. 2 pantallas]. September 2005 [consultado 23 Jun 2015]. Disponible en: http:\/\/www.eurocat-network.eu\/aboutus\/datacollection\/guidelinesforregistration\/guide1_3instructionmanual."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0300","unstructured":"StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2011."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0305","unstructured":"WHO [Internet]. Guidelines for ATC classification and DDD assignment 2013 [aprox. 3 pantallas]. Oslo: WHO; 2012 [consultado 29 Jun 2015]. Disponible en: http:\/\/www.whocc.no\/atc_ddd_index_and_guidelines\/guidelines\/."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/13625187.2013.879568","article-title":"Determinants of medication use in a multi-ethnic population of pregnant women: A cross-sectional study","volume":"19","author":"Baraka","year":"2014","journal-title":"Eur J Contracept Reprod Health Care."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2515\/therapie\/2014011","article-title":"La cohorte des grossesses du Qu\u00e9bec: pr\u00e9valences et cons\u00e9quences de l\u2019utilisation des m\u00e9dicaments durant la grossesse","volume":"69","author":"B\u00e9rard","year":"2014","journal-title":"Therapie."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bmj.320.7226.3","article-title":"Managing women with epilepsy","volume":"320","author":"Wiebe","year":"2000","journal-title":"BMJ."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0325","first-page":"66","article-title":"F\u00e1rmacos y embarazo","volume":"1762","author":"Larrubia Mu\u00f1oz","year":"2010","journal-title":"Jano."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0330","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1590\/S0124-00642010000500003","article-title":"Uso de f\u00e1rmacos durante el per\u00edodo de gestaci\u00f3n en embarazadas de Buenos Aires, Argentina","volume":"12","author":"Mar\u00edn","year":"2010","journal-title":"Rev Salud Publica (Bogota)."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0335","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/pds.2184","article-title":"Prescription drug use during pregnancy in developed countries: A systematic review","volume":"20","author":"Dawn","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0340","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.anpedi.2012.12.007","article-title":"Variaci\u00f3n temporal y distribuci\u00f3n geogr\u00e1fica: cardiopat\u00edas cong\u00e9nitas en la Comunitat Valenciana","volume":"79","author":"Cavero Carbonell","year":"2013","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0345","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bdrb.20085","article-title":"Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study","volume":"77","author":"Ofori","year":"2006","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.anpedi.2016.08.003_bib0350","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","article-title":"Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: Population based observational study and case-control study","volume":"322","author":"Nielsen","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2016.08.003_bib0355","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1157\/13117706","article-title":"Hipertensi\u00f3n pulmonar neonatal grave tras ingesti\u00f3n de antiinflamatorios no esteroideos durante el embarazo","volume":"68","author":"Chac\u00f3n Aguilar","year":"2008","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0360","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1067\/mob.2003.255","article-title":"A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac and nimesulide for the treatment of preterm labor","volume":"188","author":"Sawdy","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.anpedi.2016.08.003_bib0365","first-page":"1371","article-title":"NSAID prescribing precautions","volume":"80","author":"Risser","year":"2009","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0370","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ajmg.a.30651","article-title":"Reduction of birth prevalence rate of neural tube defects after folic acid fortification in Chile","volume":"135","author":"L\u00f3pez-Camelo","year":"2005","journal-title":"Am J Med Genet A."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0375","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/15748863113089990034","article-title":"Annual trends in use of periconceptional folic acid and birth prevalence of major congenital malformations","volume":"8","author":"Richard-Tremblay","year":"2013","journal-title":"Curr Drug Saf."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0380","first-page":"54","article-title":"Prevalencia de labio y\/o paladar fisurado y factores de riesgo","volume":"14","author":"Sacsaquispe Contreras","year":"2004","journal-title":"Rev Estomatol Herediana"},{"key":"10.1016\/j.anpedi.2016.08.003_bib0385","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gaceta.2011.10.022","article-title":"Caracterizaci\u00f3n de la suplementaci\u00f3n de folatos en el embarazo a partir de la combinaci\u00f3n de sistemas de informaci\u00f3n sanitaria","volume":"26","author":"Sanf\u00e9lix-Gimeno","year":"2012","journal-title":"Gac Sanit."},{"key":"10.1016\/j.anpedi.2016.08.003_bib0390","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S1135-57272008000600011","article-title":"Utilizaci\u00f3n de hormona de crecimiento en la Comunidad Valenciana durante el periodo 2003-2007","volume":"82","author":"Grau Rubio","year":"2008","journal-title":"Rev Esp Salud Publica"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403316302491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403316302491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T23:46:33Z","timestamp":1718840793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403316302491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1695403316302491"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2016.08.003","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consumo de medicamentos en el embarazo y riesgo de anomal\u00edas cong\u00e9nitas en la Comunitat Valenciana","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}